Leukemia News and Research

RSS
Leukemia (Leukaemia) is a cancer of the blood cells. It is the most common type of blood cancer and affects 10 times as many adults as children. Most people diagnosed with leukemia are over 50 years old. No one knows why some people develop leukemia and others do not. However, scientists have identified some risk factors for the disease. Most people who have known risk factors do not get leukemia, while many who do get the disease have none of these risk factors. During the early stages of leukemia, there may be no symptoms. Many of the symptoms of leukemia don't become apparent until a large number of normal blood cells are crowded out by leukemia cells.
Targeting a single protein can help fight both breast cancers and leukemias

Targeting a single protein can help fight both breast cancers and leukemias

EntreMed announces $10 million in financing from strategic accredited investors

EntreMed announces $10 million in financing from strategic accredited investors

Charité coordinates largest study in the world against common childhood cancer

Charité coordinates largest study in the world against common childhood cancer

Researchers create first 3D structure of key cancer protein

Researchers create first 3D structure of key cancer protein

Inherited mutation links exploding chromosomes to cancer

Inherited mutation links exploding chromosomes to cancer

Researchers reveal role of micronuclei in cancer process

Researchers reveal role of micronuclei in cancer process

Study identifies mechanism that AML cells use to evade chemotherapy

Study identifies mechanism that AML cells use to evade chemotherapy

Alpha-1-antitrypsin may reduce effects of GVHD

Alpha-1-antitrypsin may reduce effects of GVHD

'Pro-survival' protein inhibitors may improve outlook for AML patients

'Pro-survival' protein inhibitors may improve outlook for AML patients

Study shows how Notch gene and PRC2 protein complex work together to cause T-ALL

Study shows how Notch gene and PRC2 protein complex work together to cause T-ALL

Kedem commences development of Gleevec to treat CML in children and adults

Kedem commences development of Gleevec to treat CML in children and adults

First details of genetic alterations that fuel early T-cell precursor ALL

First details of genetic alterations that fuel early T-cell precursor ALL

Chemotherapy drugs can lead to relapse of leukemia

Chemotherapy drugs can lead to relapse of leukemia

St. Jude introduces 'Explore' website for pediatric genome project

St. Jude introduces 'Explore' website for pediatric genome project

Researchers identify mechanism that makes retinoblastoma so aggressive

Researchers identify mechanism that makes retinoblastoma so aggressive

Damon Runyon Cancer Research Foundation names 18 new Fellows

Damon Runyon Cancer Research Foundation names 18 new Fellows

Research identifies several new means to potentially target cancer

Research identifies several new means to potentially target cancer

New UC San Diego-Roche Extending Innovation Network program launched

New UC San Diego-Roche Extending Innovation Network program launched

Sangamo BioSciences starts Phase 2 clinical studies to develop functional cure for HIV/AIDS

Sangamo BioSciences starts Phase 2 clinical studies to develop functional cure for HIV/AIDS

BioCells opens new franchise headquartered in Campinas, Brazil

BioCells opens new franchise headquartered in Campinas, Brazil

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.